Global 3D Printing Technology in Pharmaceutical Market Size, Share, and COVID-19 Impact Analysis, By Technology (Stereolithography, Fused Deposition Modeling, Selective Laser Sintering, Inkjet Printing, and Others) By Application (Drug Development, Personalized Medicine, Medical Devices, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global 3D Printing Technology in Pharmaceutical Market Insights Forecasts to 2035

• The Global 3D Printing Technology in Pharmaceutical Market Size Was Estimated at USD 1.42 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 18.25% from 2025 to 2035
• The Worldwide 3D Printing Technology in Pharmaceutical Market Size is Expected to Reach USD 8.98 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global 3D Printing Technology in Pharmaceutical Market Size was worth around USD 1.42 Billion in 2024 and is predicted to grow to around USD 8.98 Billion by 2035 with a compound annual growth rate (CAGR) of 18.25% from 2025 to 2035. 3D printing technology has a lot of opportunities in the pharmaceutical industry due to the rising need for individualized treatment. 3D printing is perfectly suited for personalized medicine, which focuses on adjusting medical interventions to meet the needs of specific patients.

Global 3D Printing Technology in Pharmaceutical Market Forecast and Revenue Outlook

• 2024 Market Size: USD 1.42 Billion
• 2035 Projected Market Size: USD 8.98 Billion
• CAGR (2025-2035): 18.25%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

3D printing technology refers to the cutting-edge manufacturing process of fabricating three-dimensional pharmaceutical products, such as tablets, capsules, or drug-delivery devices, via the precise stacking of materials based on digital designs through advanced manufacturing methods such as inkjet printing, stereolithography, and fused deposition modeling. The 3D printing process can continue to advance the innovation of drug delivery systems and address unmet medical needs with customized pharmaceutical products and solutions in the field of pharmaceutics by mass customizing products, increasing productivity, improving efficiencies of production, reducing waste, and allowing for on-demand manufacturing.

Advances in 3D printing technology, the growing need for individualized treatment, and the growing usage of 3D printing for medical device and drug research are some of the factors driving the 3D printing technology in the pharmaceutical market. For Instance, in July 2024, BioNTech SE a next-generation immunotherapy company that is developing innovative treatments for cancer and other serious diseases, announced a research collaboration and platform technology license agreement with Triastek, Inc., a global leader in 3D printing pharmaceuticals. As per the agreement, the businesses would use 3D printing technology to produce RNA medicines for oral delivery. The development of 3D printing technology is one of the main drivers of this market's expansion.

Key Market Insights

• North America is expected to account for the largest share of the 3D printing technology in pharmaceutical market during the forecast period.
• In terms of technology, the stereolithography segment is projected to lead the 3D printing technology in pharmaceutical market throughout the forecast period
• In terms of application, the drug development segment captured the largest portion of the market  

3D Printing Technology in Pharmaceutical Market Trends

• Customized medicine Formulations: By enabling the customization of medicine doses, forms, and release profiles to meet the specific requirements of each patient, 3D printing improves treatment accuracy and patient compliance.
• The creation of single tablets that contain several medications with various release methods, known as polypills and multi-drug delivery systems, improves convenience and compliance, particularly for chronic illnesses.
• Point-of-care drug manufacture in pharmacies or hospitals is made possible by on-demand and decentralized manufacturing, which lessens reliance on conventional supply chains and enables quick responsiveness to patient-specific demands.
• Regulatory Advancement and Commercialization: Pharmaceutical businesses are being encouraged to invest in scalable and compliant 3D printing solutions as regulatory bodies such as the FDA are starting to approve 3D-printed medications.

Report Coverage

This research report categorizes the 3D printing technology in pharmaceutical market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the 3D printing technology in pharmaceutical market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the 3D printing technology in pharmaceutical market.

Driving factors

The market for 3D printing pharmaceuticals is anticipated to see significant growth and innovation due to the increasing focus on personalized medicine. The precision, speed, and versatility of 3D printing techniques have been greatly improved by advancements in technologies like Stereolithography (SLA), Fused Deposition Modeling (FDM), and Selective Laser Sintering (SLS).  Drugs and medical equipment can be customized via 3D printing to match each patient's unique requirements. The development of 3D printing technology in the pharmaceutical market is anticipated to be driven by the rising investments and advantageous regulatory frameworks in these areas.

Restraining Factor

High upfront costs, difficult regulatory compliance, limited scalability for mass production, and difficulties guaranteeing reliable quality control and intellectual property protection for decentralized manufacturing processes are some of the factors restricting the adoption of 3D printing technology in the pharmaceutical market.   

Market Segmentation 

The global 3D printing technology in pharmaceutical market is divided into technology and application.

Global 3D Printing Technology in Pharmaceutical Market, By Technology:

• The stereolithography segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.     

Based on technology, the global 3D printing technology in pharmaceutical market is segmented into stereolithography, fused deposition modeling, selective laser sintering, inkjet printing, and others. Among these, the stereolithography segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. One of the most used 3D printing techniques in the pharmaceutical industry is stereolithography (SLA). SLA enables the production of incredibly intricate and exact structures by layering liquid resin into solid forms using a laser. It is anticipated that SLA technology will continue to develop, expanding its use in the pharmaceutical industry and improving its capabilities. 

The inkjet printing segment in the 3D printing technology in pharmaceutical market is expected to grow at the fastest CAGR over the forecast period. The inkjet printing market is a result of the technology's capacity to provide accurate medicine dosages, facilitate high-resolution printing, and make it possible to create intricate and customized pharmaceutical formulations. Its affordability and versatility to different medication ingredients also increase its market potential.

Global 3D Printing Technology in Pharmaceutical Market, By Application:

• The drug development segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.    

Based on application, the global 3D printing technology in pharmaceutical market is segmented into drug development, personalized medicine, medical devices, and others. Among these, the drug development segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. One of the main factors propelling the market's expansion is the use of 3D printing in drug development. Rapid prototyping and testing of novel drug formulations is made possible by 3D printing, which can drastically cut down on the time and expense required to introduce new medications to the market.

The personalized medicine segment in the 3D printing technology in pharmaceutical market is expected to grow at the fastest CAGR over the forecast period. The use of 3D printing in the pharmaceutical industry is also significant in personalized medicine.  The capacity to use 3D printing to create customized medications on demand is revolutionizing healthcare delivery and is anticipated to generate substantial market   

Regional Segment Analysis of the Global 3D Printing Technology in Pharmaceutical Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America 3D Printing Technology in Pharmaceutical Market Trends

North America is expected to hold the largest share of the global 3D printing technology in pharmaceutical market over the forecast period.

North America is propelled by the existence of top pharmaceutical firms and cutting-edge medical facilities. The development of the pharmaceutical 3D printing market in North America is further supported by the advantageous regulatory framework and robust government backing for technical innovation. The strong network of academic institutions and biotechnology companies in North America speeds up the use of bioprinting, cutting production costs by up to 30% when compared to conventional methods and alleviating drug shortages through on-demand manufacture.

United States 3D Printing Technology in Pharmaceutical Market Trends

Research and development for pharmaceuticals is particularly concentrated in the United States, where several businesses and academic institutions are actively investigating the possibilities of 3D printing technology.  FDA approvals such as Spritam and improvements in personalized medicine have propelled the U.S. 3D printing pharmaceutical business to the top of the global rankings.

Asia Pacific 3D Printing Technology in Pharmaceutical Market Trends

Asia Pacific is expected to grow at the fastest CAGR in the 3D printing technology in pharmaceutical market during the forecast period.

The market is expanding in this area due to the fast economic development, increased healthcare spending, and growing use of cutting-edge technology in nations like China, India, and Japan. These countries are using 3D printing to develop novel medicine delivery systems, such as controlled-release formulations and customized polypills, that are intended to treat chronic illnesses that are common in the elderly. Asia Pacific's sizable and varied patient base offers enormous potential for customized medical equipment and personalized medicine. 

China 3D Printing Technology in Pharmaceutical Market Trends

China's 3D printing technology in the pharmaceutical industry is a growing sector of the rapidly expanding Asia Pacific region, driven by significant expenditures in research and development as well as government programs for advanced manufacturing. In addition to resolving supply chain weaknesses and revolutionizing globally accessible drug delivery, this places China at the forefront of sustainable, patient-centric pharmacotherapy.

Europe 3D Printing Technology in Pharmaceutical Market Trends

Europe is expected to hold a significant share of the global 3D printing technology in pharmaceutical market over the forecast period.

Europe's robust R&D efforts and advantageous regulatory environments assist the area. The European Union's financial programs and regulations that support advanced manufacturing technologies are also anticipated to accelerate market expansion. The region is expected to continue growing steadily throughout the course of the projection period, with a particular emphasis on the development of medical devices and personalized medicine.

Germany 3D Printing Technology in Pharmaceutical Market Trends

Germany's pharmaceutical 3D printing technology is a key component of Europe's thriving innovation ecosystem, which is led by prominent companies like Exentis Group AG and Merck KGaA. Strong regulatory monitoring is provided by the Federal Institute for Drugs and Medical Devices, which promotes quality assurance in the face of growing healthcare demands from an aging population.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global 3D printing technology in pharmaceutical market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players in the 3D Printing Technology in Pharmaceutical Market Include

• Carbon, Inc.
• Formlabs Inc.
• Renishaw PLC
• ExOne Company
• Materialise NV
• Proto Labs, Inc.
• Nano Dimension Ltd.
• Bioprinting Solutions
• Organovo Holdings, Inc.
• EnvisionTEC GmbH
• Desktop Metal, Inc.
• Aspect Biosystems Ltd.
• 3D Systems Corporation
• SLM Solutions Group AG
• Others 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In February 2025, the UK-based biotech business FabRx announced a study investigating the potential of pharmaceutical 3D printing to automate the filling of capsules at neighborhood pharmacies.

• In February 2025, Pharmaceutical 3D printing specialist FABRX launched a groundbreaking study utilizing its M3DIMAKER 1 printer, showcasing automated capsule manufacturing that enhances production efficiency, reduces costs, and improves patient safety through advanced quality control in compounded medication preparation.

• In September 2024, to facilitate offering the pharmaceutical industry cGMP 3D printing capabilities from Adare's Pessano facility in Milan, Italy, the global technology-driven CDMO Adare Pharma Solutions, which specializes in oral dosage forms, today announced a partnership with Laxxon Medical, a pharma-technology company that is leading a new generation of advanced pharmaceuticals.

• In November 2023, Precision drug delivery startup Aprecia is collaborating with Battelle's R&D specialists to create innovative 3D printing platforms that could revolutionize the creation, production, distribution, and administration of medications. The benefits of 3D printing technology have transformed a number of industries, and the pharmaceutical production industry is now at risk of being upended.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the 3D printing technology in pharmaceutical market based on the following segments:

 Global 3D Printing Technology in Pharmaceutical Market, By Technology

• Stereolithography
• Fused Deposition Modeling
• Selective Laser Sintering
• Inkjet Printing
• Others

Global 3D Printing Technology in Pharmaceutical Market, By Application

• Drug Development
• Personalized Medicine
• Medical Devices
• Others

Global 3D Printing Technology in Pharmaceutical Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa